Advertisement
Perspective

Why Open Drug Discovery Needs Four Simple Rules for Licensing Data and Models

  • Antony J. Williams mail,

    tony27587@gmail.com

    Affiliation: Royal Society of Chemistry, Wake Forest, North Carolina, United States of America

    X
  • John Wilbanks,

    Affiliation: Consent to Research, Oakland, California, United States of America

    X
  • Sean Ekins

    Affiliation: Collaborations in Chemistry, Fuquay-Varina, North Carolina, United States of America

    X
  • Published: September 27, 2012
  • DOI: 10.1371/journal.pcbi.1002706

Reader Comments (1)

Post a new comment on this article

Publisher's Note: Change public domain to "public"

Posted by ChemConnector on 01 Oct 2012 at 16:56 GMT

public domain
http://ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1002706#article1.body1.sec1.p1

The term public domain does carry explicit meaning regarding the licensing of the data. This has been picked up by one of the readers of the article. We request a change of public domain to "public", with the inverted commas included, to clarify this situation.

No competing interests declared.